FairJourney Bio

📍 Porto, Portugal🗓 Founded 2012👥 300 employees💰 Last funded Jan 2026
Biotechnology Research🌐 fjbio.com
Website LinkedIn
At FairJourney Bio, we specialize in cutting-edge antibody discovery and development, offering end-to-end solutions that fast-track your research. With over a decade of expertise, our innovative technologies and seasoned team have successfully advanced 19 antibodies to clinical stages. Our adaptable partnership model empowers projects of any scale, fostering collaboration and breakthrough innovation. Whether youre in early-stage research or development, we deliver tailored, high-quality antibodies designed to meet your specific needs. Join us in revolutionizing therapeutic discovery and making lasting impacts on global healthcare.
4
Total investors
0
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Switzerland
2
United Kingdom
1
United States
1
Investor activity2020–2026 · investors recorded per year
202012024220261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in FairJourney Bio?
FairJourney Bio has 4 investors on record on gritt.io and 1 late-stage investors.
When did FairJourney Bio last raise funding?
The most recent investment in FairJourney Bio recorded on gritt.io was in January 2026.
When was FairJourney Bio founded?
FairJourney Bio was founded in 2012.
What industry is FairJourney Bio in?
FairJourney Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is FairJourney Bio based?
FairJourney Bio is headquartered in Porto, Portugal.